/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the second quarter ended June 30,.
PreventionGenetics selected to join Concert Genetics Preferred Laboratory Network
News provided by
Share this article
Share this article
MARSHFIELD, Wis., Jan. 19, 2021 /PRNewswire/ With more than 150,000 genetic tests available, at least 6.9 codes per claim and thousands of medical policies
1,2, it s virtually impossible for providers and payers to keep up with the complex and ever-changing world of genetic testing. Today, PreventionGenetics joins Concert Genetics Preferred Laboratory Network, which brings health plans and preferred laboratories together to ensure that the quality, pricing and service information needed for decision-making is at the forefront and eases the administrative burden involved in insurance claims processing for genetic testing.